Cummings, A. L., & Garon, E. B. (2019). KEYNOTE-042 rolls back programmed cell death ligand 1 threshold for non-small cell lung cancer pembrolizumab monotherapy without new insight into those deriving benefit. Transl Lung Cancer Res.
Citação norma ChicagoCummings, Amy Lauren, and Edward B. Garon. "KEYNOTE-042 Rolls Back Programmed Cell Death Ligand 1 Threshold for Non-small Cell Lung Cancer Pembrolizumab Monotherapy Without New Insight Into Those Deriving Benefit." Transl Lung Cancer Res 2019.
Citação norma MLACummings, Amy Lauren, and Edward B. Garon. "KEYNOTE-042 Rolls Back Programmed Cell Death Ligand 1 Threshold for Non-small Cell Lung Cancer Pembrolizumab Monotherapy Without New Insight Into Those Deriving Benefit." Transl Lung Cancer Res 2019.